Livio Pellizzoni Selected Research

trichostatin A (A 300)

1/2023	Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy.
3/2007	Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Livio Pellizzoni Research Topics

Disease

28	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 02/2023 - 08/2002
12	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 08/2002
3	Atrophy 01/2022 - 10/2016
3	Motor Neuron Disease (Primary Lateral Sclerosis) 08/2014 - 09/2007
2	Neuroinflammatory Diseases 02/2023 - 01/2021
1	Weight Gain 04/2024
1	Weight Loss (Weight Reduction) 03/2007
1	Neuromuscular Diseases (Neuromuscular Disease) 12/2005
1	Spinal Diseases (Disease, Spinal) 03/2002
1	Muscular Atrophy (Muscle Atrophy) 03/2002

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2002
3	Small Nuclear Ribonucleoproteins (snRNP)IBA 01/2021 - 11/2002
2	nusinersenIBA 02/2023 - 10/2022
2	trichostatin A (A 300)IBA 01/2023 - 03/2007
2	Messenger RNA (mRNA)IBA 01/2022 - 08/2014
1	xylometazoline (stas)IBA 04/2024
1	Tamoxifen FDA LinkGeneric 04/2024
1	Cre recombinaseIBA 04/2024
1	Antisense OligonucleotidesIBA 10/2022
1	Histones (Histone)IBA 01/2022
1	U7 Small Nuclear Ribonucleoprotein (U7 snRNP)IBA 01/2022
1	Butyrates (Butyrate)IBA 05/2016
1	RNA (Ribonucleic Acid)IBA 08/2014
1	2,4-diaminoquinazolineIBA 02/2010
1	RibonucleoproteinsIBA 09/2007
1	theasinensin AIBA 03/2007
1	SMN Complex ProteinsIBA 11/2002

Therapy/Procedure

2	Therapeutics 02/2023 - 10/2022
1	Denervation 01/2022